JB/CALL/GALENICA/75/0.05/20.09.24 | Market Closed - Swiss Exchange 08:50:00 28/06/2024 pm IST | ||
| 0.11 CHF | -15.38% |
|
| 1 month | -8.33% | ||
| 3 months | -31.25% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
GALENICA AG
| Date | Price | Change |
|---|---|---|
| 28/24/28 | 0.11 | -15.38% |
| 25/24/25 | 0.13 | -7.14% |
| 24/24/24 | 0.14 | +7.69% |
Delayed Quote Swiss Exchange
Last update June 28, 2024 at 08:50 pm IST
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | GALENICA AG |
| Issuer | Bank Julius Bär |
| GAZCJB | |
| ISIN | CH1263886769 |
| Date issued | 07/06/2023 |
| Strike | 75 CHF |
| Maturity | 20/09/2024 (81 Days) |
| Parity | 20 : 1 |
| Emission price | 0.32 CHF |
| Emission volume | N/A |
| Settlement | both |
| Currency | CHF |
Technical Indicators
| Highest since issue | 0.31 CHF |
|---|---|
| Lowest since issue | 0.08 CHF |
| Spread | 0.01 CHF |
| Spread % | 8.33% |
Company Profile
Galenica AG, previously Galenica Sante Ltd, is a Switzerland-based healthcare services and products provider. The Company's business i divided into three business sectors: Retail, Products & Brands, and Services. The Company manages a locally established pharmacies network in Switzerland. It develops and distributes its own product portfolio, as well as cooperates with a range of business partners, such as Pierre Fabre, Ales Groupe and Vitor Consumer Health for marketing and distribution of such brands as Perskindol, Triofan, A-Derma, Lierac, Phyto, Anti-Brumm and Algifor. Galenica Sante's Services business sector is responsible for management of such logistics sector companies as Galexis, Unione Farmaceutica Distribuzione, Alloga and Medifilm.
Sector
-
Consensus: Galenica AG
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
73.6
CHF
Average target price
77
CHF
Spread / Average Target
+4.62%
- Stock Market
- Warrants
- GAZCJB Warrant
